2024 Oncology Year in Review (RP2407A)

Dallas, TX US
December 7, 2024

This program will provide participants with the latest information available as presented at the 2024 American Society of Clinical Oncology (ASCO) meeting, 2024 European Society for Medical Oncology (ESMO) meeting, and major findings from other meetings that took place in 2024. Oncology/Hematology faculty members from UT Southwestern Medical Center will provide participants with analysis of the more clinically applicable presentations from this year's national conferences via disease-specific didactic talks and panel discussions. 

Click HERE to download Agenda!

Register today! 

Registration CategoryBefore 10/31/2411/1/24-12/4/24Late/Onsite 12/7/24
Physicians (MD/DO)$50$75$100
Fellows or Advanced Practitioners (PA/NP)$25$50$75
Nurses$25$50$75
Residents or Medical Students$25$50$75
Other Healthcare Professional$25$50$75
Exhibit/Industry Representative$75$100$125

Target Audience

This activity is appropriate for oncologists (from the community and from UT Southwestern), nurse practitioners, physician assistants, oncology nurses, oncology fellows, residents, and students interested in the treatment of cancer.

Learning Objectives

  1. Recall and describe the newest developments in the treatment of breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, head/neck cancer, melanoma, and hematological malignancies.
  2. Discuss the integration of multimodality treatment strategies, including radiation therapy, chemotherapy, immunotherapy, and targeted therapy into the management of patients with cancer.
Course summary
Available credit: 
  • 5.00 AMA
  • 5.00 Attendance
Course opens: 
03/01/2024
Course expires: 
12/07/2025
Event starts: 
12/07/2024 - 8:00am CST
Event ends: 
12/07/2024 - 3:00pm CST
Cost:
$100.00
Add to calendar: 
Rating: 
0
UT Southwestern Medical Center
2280 Inwood Road
Radiation Oncology Building (EC) - 3rd Floor
Dallas, TX 75235
United States

This conference is scheduled to take place in-person. Live-stream and/or Hybrid options are not available. 

Parking

Visitor parking is available in the open lot directly in front of the building or in the parking garage adjacent to the building. Please follow signs to garage entrance. Enter the Radiation Oncology Building (with green columns in the driveway) through the main entrance on the ground floor and take the elevators (found left of the information desk) to the third floor. Follow the directional signs to the conference room. Parking is complimentary.

 

Travel

Recommended Nearby Accommodations

Aloft Dallas Love Field

Le Meridien Dallas, The Stoneleigh

Renaissance Dallas Hotel

DoubleTree by Hilton Hotel Dallas - Love Field

Course Director(s)

Sawsan Rashdan

has a financial relationship (Professional Services) with AZ;.
has a financial relationship (Professional Services) with Taekeda;.
has a financial relationship (Professional Services) with Cardinal Health;.
has a financial relationship (Professional Services) with Oncohost;.
has a financial relationship (Professional Services) with Catalyst;.
Moderator(s)

Sawsan Rashdan

has a financial relationship (Professional Services) with Cardinal Health;.
has a financial relationship (Professional Services) with Oncohost;.
has a financial relationship (Professional Services) with Catalyst;.
has a financial relationship (Professional Services) with AZ;.
has a financial relationship (Professional Services) with Taekeda;.
Peer reviewer(s)

Daniel Wang

has no relevant financial relationships to disclose at this time.
Speaker(s)

Salwan Al Mutar, M.D.

has no relevant financial relationships to disclose at this time.

Larry Anderson, MD, PhD

has a financial relationship (Professional Services) with GSK;.
has a financial relationship (Professional Services) with Beigene;.
has a financial relationship (Professional Services) with amgen;.
has a financial relationship (Professional Services) with Prothena;.
has a financial relationship (Professional Services) with Cellectar;.
has a financial relationship (Professional Services) with Celgene;.
has a financial relationship (Professional Services) with BMS;.
has a financial relationship (Professional Services) with Abbvie;.
has a financial relationship (Professional Services) with Janssen;.
has a financial relationship (Professional Services) with Sanofi;.

Isaac Chan, MD, PhD

has no relevant financial relationships to disclose at this time.

Kevin Courtney, MD, PhD

has a financial relationship (Independent contractor) with Novartis;.
has a financial relationship (Patent) with Athena Diagnostics;.

David Gerber, MD

has a financial relationship (Grant Or Contract) with Sagimet;.
has a financial relationship (Independent contractor) with Sanofi;.
has a financial relationship (Independent contractor) with Daichii Sankyo;.
has a financial relationship (Grant Or Contract) with Novocure;.
has a financial relationship (Grant Or Contract) with AstraZeneca;.
has a financial relationship (Independent contractor) with Janssen;.
has a financial relationship (Independent contractor) with Elevation Oncology;.
has a financial relationship (Independent contractor) with Astra Zeneca;.
has a financial relationship (Grant Or Contract) with BerGenBio;.
has a financial relationship (Independent contractor) with Catalyst Therapeutics;.
has a financial relationship (Stock) with Walgreens;.
has a financial relationship (Independent contractor) with Jazz Pharmaceuticals;.
has a financial relationship (Grant Or Contract) with Karyopharm;.
has a financial relationship (Stock) with Gilead;.
has a financial relationship (Independent contractor) with Regeneron;.
has a financial relationship (Intellectual Property Other) with OncoSeer Diagnostics;.
has a financial relationship (Independent contractor) with GSK;.

David Hsieh, MD

has no relevant financial relationships to disclose at this time.

Randall Hughes, M.D, Professor of Internal Medicine

has no relevant financial relationships to disclose at this time.
has no relevant financial relationships to disclose at this time.

Syed Kazmi

has a financial relationship (Stock) with Johnson & Johnson;.

Heather McArthur, Heather McArthur, MD, MPH

has a financial relationship (Independent contractor) with Moderna;.
has a financial relationship (Independent contractor) with Merck;.
has a financial relationship (Independent contractor) with AstraZeneca;.
has a financial relationship (Independent contractor) with Pfizer;.
has a financial relationship (Independent contractor) with Daiichi-Sankyo;.
has a financial relationship (Independent contractor) with Seattle Genetics;.

Daniel Wang

has no relevant financial relationships to disclose at this time.

Tian Zhang, MD, MHS

has a financial relationship (Independent contractor) with Pfizer, MJH Associates, Vaniam, Aptitude Health, PeerView, Clinical Care Options, Mashup Media;.
has a financial relationship (Grant Or Contract) with Pfizer, Eli Lilly, Tempus, ALX Oncology, Exelixis, Merck, OncoC4;.
has a financial relationship (Independent contractor) with Merck, Exelixis, Sanofi-Aventis, Janssen, AstraZeneca, Pfizer, BMS, SeaGen, Eisai, Aveo Pharmaceuticals, Bayer, Eli Lilly, Novartis, Gilead, EMD Serono;.

The University of Texas Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Texas Southwestern Medical Center designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 5.00 AMA
  • 5.00 Attendance

Price

Cost:
$100.00
Please login or create an account to take this course.

Registration

To register:

  1. "Login" to your existing account or create an account in EthosCE, online learning management system, by selecting the "create an account" link.
  2. Once logged in, return to this course page, select the designated fee and click the "add to cart" button.
  3. In the following "checkout" pages you will verify and process your payment.
  4. After registration is completed, a confirmation will be sent by email.

A $25 handling fee will be deducted from cancellation refunds. Refund requests must be received by email at CEOffice@utsouthwestern.edu by Nov 22, 2024.  No refunds will be made thereafter.